quinoxalines has been researched along with cysteine in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.13) | 18.7374 |
| 1990's | 8 (25.00) | 18.2507 |
| 2000's | 13 (40.63) | 29.6817 |
| 2010's | 8 (25.00) | 24.3611 |
| 2020's | 2 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Damgaard, I; Dunlop, J; Grieve, A; Griffiths, R; Schousboe, A | 1 |
| Gundersen, CB; Umbach, JA | 1 |
| Hagberg, H; Lehmann, A; Orwar, O; Sandberg, M | 1 |
| Branka, JE; Jarry, A; Laboisse, CL; Vallette, G | 1 |
| Bahia, DS; Fanelli, F; Lee, M; Milligan, G; Rees, S; Wise, A | 1 |
| Bahia, DS; Jackson, VN; Milligan, G | 1 |
| Frölich, JC; Ikic, M; Raida, M; Tewes, KS; Tsikas, D | 1 |
| Adams, A; Berger, J; Chen, Y; Elbrecht, A; Griffin, P; Klatt, T; Menke, J; Moller, DE; Smith, RG; Zhang, B; Zhou, G | 1 |
| Jacklet, JW; Koh, HY | 1 |
| Cockcroft, V; Frang, H; Marjamäki, A; Pihlavisto, M; Scheinin, M | 1 |
| Kato, T; Nakamura, K; Yamamoto, H; Yamamoto, T; Yuyama, K | 1 |
| Buxton, IL; Kaiser, RA; Malmquist, NA; Tichenor, S | 1 |
| Favaloro, JL; Irvine, JC; Kemp-Harper, BK | 1 |
| Akaike, A; Kaneko, S; Katsuki, H; Kume, T; Nishikawa, H; Sugimoto, H; Taguchi, R; Terauchi, T; Yonaga, M | 1 |
| Fukushima, S; Nakae, D; Nishkawa, T; Ogawa, M; Otani, S; Totsuka, Y; Wakabayashi, K; Wanibuchi, H; Yano, Y | 1 |
| Jayaraman, V | 1 |
| Bryan-Lluka, LJ; Paczkowski, FA; Papacostas, MH; Wanstall, JC | 1 |
| Fukushima, S; Hayashi, S; Kinoshita, A; Morimura, K; Nishikawa, T; Nishikawa-Ogawa, M; Wanibuchi, H; Yano, Y | 1 |
| Matschke, K; Waldow, T; Weber, E; Witt, W | 1 |
| Lerma, J; Priel, A; Selak, S; Stern-Bach, Y | 1 |
| Favaloro, JL; Irvine, JC; Kemp-Harper, BK; Widdop, RE | 1 |
| Favaloro, JL; Kemp-Harper, BK | 1 |
| Lu, L; Shimizu, T; Tanaka, K; Yokotani, K | 1 |
| Arancio, O; Fa', M; Schiefer, IT; Thatcher, GR; VandeVrede, L | 1 |
| Borsotto, M; Gallego, D; Gil, V; Heurteaux, C; Jiménez, M; Martínez-Cutillas, M; Moha Ou Maati, H; Peyronnet, R | 1 |
| Blachowicz, L; Ghisi, V; Lau, AY; Plested, AJ; Roux, B; Salazar, H | 1 |
| Brizuela, M; Burgio, G; Foote, SJ; Huang, HM; McMorran, BJ; Smith, C | 1 |
| Li, M; Sobolevsky, AI; Yelshanskaya, MV | 1 |
| Blood, AB; Liu, T; Longo, LD; Power, GG; Schroeder, HJ; Terry, MH; Wilson, SM; Zhang, M | 1 |
| He, ZX; Jiao, QC; Xu, J; Yang, B; Yuan, ZH; Zheng, DJ; Zhu, HL | 1 |
| Gan, Y; Li, H; Yin, G; Yin, P; Yu, T; Zhang, Y | 1 |
| Capelletti, MM; Manceau, H; Peoc'h, K; Puy, H | 1 |
1 review(s) available for quinoxalines and cysteine
| Article | Year |
|---|---|
Ferroptosis in Liver Diseases: An Overview.
Topics: alpha-Tocopherol; Animals; Autophagy; Chemical and Drug Induced Liver Injury; Cyclohexylamines; Cysteine; Ferroptosis; Glutathione; Heme; Humans; Iron; Kelch-Like ECH-Associated Protein 1; Lipid Peroxidation; Lipoxygenase; Liver Diseases; Liver Neoplasms; Oxidative Stress; Phenylenediamines; Phospholipid Hydroperoxide Glutathione Peroxidase; Piperazines; Quinoxalines; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction; Sorafenib; Spiro Compounds; Sulfasalazine; Tumor Suppressor Protein p53 | 2020 |
31 other study(ies) available for quinoxalines and cysteine
| Article | Year |
|---|---|
Sulphur-containing excitatory amino acid-evoked Ca(2+)-independent release of D-[3H]aspartate from cultured cerebellar granule cells: the role of glutamate receptor activation coupled to reversal of the acidic amino acid plasma membrane carrier.
Topics: Animals; Aspartic Acid; Calcium; Carrier Proteins; Cell Membrane; Cells, Cultured; Cerebellum; Cysteine; Glutamates; Homocysteine; Mice; Mice, Inbred Strains; Neurons; Neurotransmitter Agents; Quinoxalines; Rats; Rats, Wistar; Receptors, Glutamate; Synaptosomes; Tritium | 1992 |
Mercuric ions are potent noncompetitive antagonists of human brain kainate receptors expressed in Xenopus oocytes.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Cysteine; Electric Conductivity; Humans; In Vitro Techniques; Kainic Acid; Mercury; Oocytes; Quinoxalines; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Recombinant Proteins; Sulfhydryl Reagents; Xenopus laevis | 1989 |
Cysteine sulphinate and cysteate: mediators of cysteine toxicity in the neonatal rat brain?
Topics: Amino Acids; Animals; Animals, Newborn; Brain; Cerebral Cortex; Cysteic Acid; Cysteine; Dizocilpine Maleate; Female; Male; Nerve Degeneration; Neurons; Neurotoxins; Neurotransmitter Agents; Organ Specificity; Quinoxalines; Rats; Rats, Sprague-Dawley | 1993 |
Stimulation of mucin exocytosis from human epithelial cells by nitric oxide: evidence for a cGMP-dependent and a cGMP-independent pathway.
Topics: 1-Methyl-3-isobutylxanthine; Cyclic GMP; Cysteine; Enzyme Inhibitors; Epithelium; Exocytosis; Guanylate Cyclase; Humans; Hydrazines; Mucins; Nitric Oxide; Nitroprusside; Oxadiazoles; Quinoxalines; Reactive Oxygen Species; Superoxide Dismutase | 1997 |
Hydrophobicity of residue351 of the G protein Gi1 alpha determines the extent of activation by the alpha 2A-adrenoceptor.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Amino Acid Sequence; Animals; Brimonidine Tartrate; Cell Line; Cysteine; Glycine; GTP-Binding Protein alpha Subunits, Gi-Go; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Kidney; Molecular Sequence Data; Mutagenesis, Site-Directed; Pertussis Toxin; Protein Binding; Quinoxalines; Rats; Receptors, Adrenergic, alpha-2; Transfection; Virulence Factors, Bordetella | 1998 |
Modulation of relative intrinsic activity of agonists at the alpha-2A adrenoceptor by mutation of residue 351 of G protein gi1alpha.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Clonidine; COS Cells; Cysteine; Dose-Response Relationship, Drug; Epinephrine; Glycine; GTP Phosphohydrolases; GTP-Binding Protein alpha Subunits, Gi-Go; Point Mutation; Quinoxalines; Radioligand Assay; Receptors, Adrenergic, alpha-2; Recombinant Fusion Proteins; Swine; Yohimbine | 1999 |
Inhibition of platelet aggregation by S-nitroso-cysteine via cGMP-independent mechanisms: evidence of inhibition of thromboxane A2 synthesis in human blood platelets.
Topics: Arachidonic Acid; Aspirin; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Collagen; Cyclic GMP; Cysteine; Fatty Acids, Unsaturated; Glutathione; Guanylate Cyclase; Humans; Hydrazines; Inhibitory Concentration 50; Nitric Oxide; Nitrites; Nitroprusside; Nitroso Compounds; Oxadiazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Quinoxalines; S-Nitrosoglutathione; S-Nitrosothiols; Thromboxane A2 | 1999 |
L-764406 is a partial agonist of human peroxisome proliferator-activated receptor gamma. The role of Cys313 in ligand binding.
Topics: Amino Acid Sequence; Animals; Binding Sites; COS Cells; Cysteine; Humans; Kinetics; Ligands; Mass Spectrometry; Molecular Sequence Data; Protein Conformation; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship; Thiazoles; Thiazolidinediones; Transcription Factors | 1999 |
Nitric oxide stimulates cGMP production and mimics synaptic responses in metacerebral neurons of Aplysia.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Aminoquinolines; Animals; Aplysia; Cyclic GMP; Cysteine; Enzyme Inhibitors; Excitatory Postsynaptic Potentials; Ganglia, Invertebrate; Guanylate Cyclase; Immunohistochemistry; Neurons; Nitric Oxide; Nitroso Compounds; Oxadiazoles; Quinoxalines; S-Nitrosothiols; Stimulation, Chemical | 1999 |
Ligand recognition of serine-cysteine amino acid exchanges in transmembrane domain 5 of alpha2-adrenergic receptors by UK 14,304.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Binding Sites; Binding, Competitive; Brimonidine Tartrate; Chlorpromazine; CHO Cells; Cricetinae; Cysteine; Dopamine Antagonists; Humans; Idazoxan; Ligands; Mice; Models, Molecular; Molecular Sequence Data; Oxymetazoline; Protein Structure, Tertiary; Quinoxalines; Radioligand Assay; Receptors, Adrenergic, alpha-2; Sequence Homology, Amino Acid; Serine; Transfection; Tritium; Yohimbine | 2000 |
Kinetic characterization of the nitric oxide toxicity for PC12 cells: effect of half-life time of NO release.
Topics: Animals; Antioxidants; Ascorbic Acid; Cell Survival; Cyclic GMP; Cysteine; Dibutyryl Cyclic GMP; DNA; DNA Fragmentation; Dose-Response Relationship, Drug; Glutathione; Half-Life; Kinetics; Nitric Oxide; Nitro Compounds; Oxadiazoles; PC12 Cells; Quinoxalines; Rats; Time Factors | 2000 |
NO-induced relaxation of labouring and non-labouring human myometrium is not mediated by cyclic GMP.
Topics: Charybdotoxin; Cyclic GMP; Cysteine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Guanylate Cyclase; Humans; In Vitro Techniques; Labor, Obstetric; Molsidomine; Muscle Relaxation; Muscle, Smooth; Myometrium; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Oxytocin; Penicillamine; Peptides; Pregnancy; Quinoxalines; S-Nitrosothiols; Scorpion Venoms; Time Factors; Uterus | 2001 |
NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries.
Topics: Animals; Arteries; Benzoates; Culture Techniques; Cysteine; Enzyme Activation; Enzyme Inhibitors; Free Radical Scavengers; Guanylate Cyclase; Imidazoles; Male; Nitric Oxide Donors; Nitrites; Nitrogen Oxides; Nitroprusside; Oxadiazoles; Potassium; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Quinoxalines; Rats; Rats, Inbred WKY; Vascular Resistance; Vasodilation | 2003 |
Serofendic acid prevents acute glutamate neurotoxicity in cultured cortical neurons.
Topics: Animals; Calcium; Cattle; Cell Survival; Cells, Cultured; Cerebral Cortex; Cysteine; Diterpenes; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Combinations; Fetal Blood; Fetus; Ionomycin; Neurons; Neurotoxicity Syndromes; Nitric Oxide; Quinoxalines; Rats; S-Nitrosothiols; Sodium Glutamate; Time Factors; Valine | 2003 |
Post-initiation inhibition of MeIQx hepatocarcinogenesis in rats by cysteine.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Cysteine; Deoxyguanosine; DNA; Genes, p53; Insulin-Like Growth Factor I; Liver Neoplasms, Experimental; Male; Nucleolus Organizer Region; Precancerous Conditions; Quinoxalines; Rats; Rats, Inbred F344 | 2003 |
Spectroscopic and kinetic methods for ligand-protein interactions of glutamate receptor.
Topics: Chemistry Techniques, Analytical; Cysteine; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Kinetics; Ligands; Protein Binding; Quinoxalines; Receptors, Glutamate; Spectroscopy, Fourier Transform Infrared | 2004 |
Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT).
Topics: Animals; Biological Transport; Catalase; Chlorocebus aethiops; COS Cells; Culture Media; Cysteine; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Inhibitors; Free Radical Scavengers; Guanylate Cyclase; Humans; Hydroxocobalamin; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Nerve Tissue Proteins; Nitric Oxide Donors; Nitro Compounds; Oxadiazoles; Peroxynitrous Acid; Piperazines; Quinoxalines; Serotonin; Serotonin Plasma Membrane Transport Proteins; Superoxide Dismutase; Transfection | 2004 |
N-acetylcysteine and S-methylcysteine inhibit MeIQx rat hepatocarcinogenesis in the post-initiation stage.
Topics: Acetylcysteine; Animals; Anticarcinogenic Agents; Carcinogens; Cell Proliferation; Cysteine; Down-Regulation; Glutathione Transferase; Insulin-Like Growth Factor I; Liver Neoplasms; Nitric Oxide Synthase Type II; Placenta; Quinoxalines; Rats; Silver Staining; Time Factors | 2006 |
Nitric oxide donor-induced persistent inhibition of cell adhesion protein expression and NFkappaB activation in endothelial cells.
Topics: Cell Adhesion Molecules; Cells, Cultured; Cyclic GMP; Cysteine; Endothelial Cells; Guanylate Cyclase; Humans; I-kappa B Kinase; I-kappa B Proteins; Interleukin-1; Lipopolysaccharides; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide Donors; Oxadiazoles; Quinoxalines; S-Nitroso-N-Acetylpenicillamine; Thionucleotides; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2006 |
Block of kainate receptor desensitization uncovers a key trafficking checkpoint.
Topics: Animals; Cells, Cultured; Cysteine; Enzyme-Linked Immunosorbent Assay; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; GluK2 Kainate Receptor; Glutamic Acid; Green Fluorescent Proteins; Hippocampus; Humans; Kainic Acid; Membrane Potentials; Models, Biological; Mutation; Neurons; Oocytes; Patch-Clamp Techniques; Protein Structure, Tertiary; Protein Transport; Quinoxalines; Receptors, AMPA; Receptors, Kainic Acid; Structure-Activity Relationship; Transfection; Xenopus | 2006 |
Nitroxyl anion donor, Angeli's salt, does not develop tolerance in rat isolated aortae.
Topics: Animals; Aorta, Thoracic; Benzoates; Cyclic GMP-Dependent Protein Kinases; Cysteine; Drug Tolerance; Enzyme Inhibitors; Free Radical Scavengers; Hydrazines; Imidazoles; In Vitro Techniques; Male; Nitric Oxide; Nitric Oxide Donors; Nitrites; Nitrogen Oxides; Nitroglycerin; Oxadiazoles; Quinoxalines; Rats; Rats, Inbred WKY; Time Factors; Vasodilation | 2007 |
Redox variants of NO (NO{middle dot} and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms.
Topics: 4-Aminopyridine; Animals; Cyclic GMP; Cysteine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Free Radical Scavengers; Guanylate Cyclase; In Vitro Techniques; Male; Membrane Potentials; Mesenteric Artery, Superior; Muscle, Smooth, Vascular; Nitric Oxide; Nitrites; Nitrogen Oxides; Oxadiazoles; Oxidation-Reduction; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Vascular Resistance; Vasodilation; Vasodilator Agents | 2009 |
Possible involvement of S-nitrosylation of brain cyclooxygenase-1 in bombesin-induced central activation of adrenomedullary outflow in rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenal Medulla; Animals; Benzoates; Bombesin; Brain; Catecholamines; Cysteine; Dithiothreitol; Dose-Response Relationship, Drug; Ethylmaleimide; Imidazoles; Injections, Intraventricular; Male; Molsidomine; Nitric Oxide Donors; Oxadiazoles; Paraventricular Hypothalamic Nucleus; Quinoxalines; Rats; Rats, Wistar; S-Nitrosothiols; Sulfhydryl Reagents | 2012 |
Furoxans (1,2,5-oxadiazole-N-oxides) as novel NO mimetic neuroprotective and procognitive agents.
Topics: Amyloid beta-Peptides; Animals; Cells, Cultured; Crystallography, X-Ray; Cysteine; Guanylate Cyclase; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Neurons; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Donors; Nootropic Agents; Oxadiazoles; Peptidomimetics; Quinoxalines; Rats; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Soluble Guanylyl Cyclase; Stereoisomerism; Structure-Activity Relationship; Synapses | 2012 |
Relative contribution of SKCa and TREK1 channels in purinergic and nitrergic neuromuscular transmission in the rat colon.
Topics: Animals; Apamin; Colon; Cysteine; Male; Methionine; Muscle Relaxation; Nitroarginine; Nitroprusside; Oxadiazoles; Peptides; Potassium Channel Blockers; Potassium Channels, Tandem Pore Domain; Quinoxalines; Rats; Rats, Sprague-Dawley; Small-Conductance Calcium-Activated Potassium Channels; Synaptic Transmission | 2012 |
A conformational intermediate in glutamate receptor activation.
Topics: Benzothiadiazines; Biophysical Phenomena; Cell Line, Transformed; Crystallography, X-Ray; Cysteine; Dithionitrobenzoic Acid; Dose-Response Relationship, Drug; Electric Stimulation; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; In Vitro Techniques; Membrane Potentials; Models, Molecular; Molecular Conformation; Mutation; Patch-Clamp Techniques; Phenanthrolines; Protein Structure, Tertiary; Quinoxalines; Receptors, Glutamate; Uncoupling Agents | 2013 |
Treatment of erythrocytes with the 2-cys peroxiredoxin inhibitor, Conoidin A, prevents the growth of Plasmodium falciparum and enhances parasite sensitivity to chloroquine.
Topics: Animals; Antimalarials; Apoptosis; Cells, Cultured; Chloroquine; Cysteine; Erythrocytes; Homeodomain Proteins; Humans; Immunoblotting; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinoxalines | 2014 |
Structure of an agonist-bound ionotropic glutamate receptor.
Topics: Animals; Cross-Linking Reagents; Crystallography, X-Ray; Cysteine; Glutamic Acid; HEK293 Cells; Humans; Ion Channel Gating; Models, Chemical; Organophosphonates; Protein Structure, Secondary; Protein Structure, Tertiary; Pyrimidinones; Quinoxalines; Rats; Receptors, AMPA | 2014 |
S-nitrosothiols dilate the mesenteric artery more potently than the femoral artery by a cGMP and L-type calcium channel-dependent mechanism.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic GMP; Cysteine; Diltiazem; Female; Femoral Artery; Fetus; Indazoles; Male; Mesenteric Arteries; Nifedipine; Oxadiazoles; Quinoxalines; S-Nitrosoglutathione; S-Nitrosothiols; Sheep; Soluble Guanylyl Cyclase; Vasodilation; Vasodilator Agents | 2016 |
A new selective fluorescence probe with a quinoxalinone structure (QP-1) for cysteine and its application in live-cell imaging.
Topics: Animals; Cell Survival; Cysteine; Fluorescent Dyes; HeLa Cells; Humans; Optical Imaging; Quinoxalines; Rats | 2018 |
A novel fluorescent probe for selective imaging of cellular cysteine with large Stokes shift and high quantum yield.
Topics: Animals; Cells, Cultured; Cysteine; Fluorescent Dyes; Mice; Molecular Structure; Optical Imaging; Pyrrolidines; Quantum Theory; Quinoxalines; RAW 264.7 Cells | 2020 |